Colgate-Palmolive (CL) Holdings Raised by Lynch & Associates IN
Lynch & Associates IN lifted its stake in Colgate-Palmolive (NYSE:CL) by 2.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,095 shares of the company’s stock after buying an additional 781 shares during the period. Lynch & Associates IN’s holdings in Colgate-Palmolive were worth $2,422,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after buying an additional 2,903,800 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in Colgate-Palmolive by 25.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after purchasing an additional 1,385,946 shares during the period. First Eagle Investment Management LLC lifted its stake in Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after purchasing an additional 1,750,417 shares during the period. Finally, Harding Loevner LP lifted its stake in Colgate-Palmolive by 92.0% during the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after purchasing an additional 2,272,675 shares during the period. Institutional investors and hedge funds own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $77.38 on Tuesday. The firm has a market cap of $68,053.16, a P/E ratio of 29.88, a PEG ratio of 3.24 and a beta of 0.80. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.91.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s payout ratio is 61.78%.
CL has been the subject of a number of analyst reports. Citigroup cut their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research note on Monday, October 23rd. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research note on Tuesday, December 19th. Finally, SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price target for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have issued a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $76.45.
In related news, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total value of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total transaction of $539,702.50. Following the completion of the sale, the insider now directly owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. In the last three months, insiders sold 181,950 shares of company stock valued at $13,237,385. 1.02% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2018/01/23/colgate-palmolive-cl-holdings-raised-by-lynch-associates-in.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.